Adial Pharmaceuticals, Inc. ("Adial" or the "Company"), which recently acquired Azora Therapeutics, announced the appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist. Dr. Rubenstein will ...
Watch the Video Visualizer HERE! New Studio Album Numbers Out January 8, 2027, via Napalm Records | Pre-Order Your Copy ...